SNTI
SNTI
NASDAQ · Biotechnology

Senti Biosciences Inc

$0.15
0.00 (-0.54%)
Financial Highlights (FY 2026)
Revenue
31.1K
Net Income
-85,107,885
Gross Margin
—
Profit Margin
-279,263.6%
Rev Growth
-82.8%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — — 52.7% 52.7%
Operating Margin -312,631.8% -281,369.8% 7.9% 7.6%
Profit Margin -279,263.6% -265,300.5% 8.0% 5.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 31.1K 180.6K 15.18M 16.45M
Gross Profit — — 8.01M 8.68M
Operating Income -97,369,180 -508,013,113 1.19M 1.25M
Net Income -85,107,885 -444,041,139 1.21M 962.0K
Gross Margin — — 52.7% 52.7%
Operating Margin -312,631.8% -281,369.8% 7.9% 7.6%
Profit Margin -279,263.6% -265,300.5% 8.0% 5.9%
Rev Growth -82.8% -82.8% +1.7% +13.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 3.21M 3.14M
Total Equity — — 9.87M 10.49M
D/E Ratio — — 0.33 0.30
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -91,489,575 -503,855,630 1.98M 2.22M
Free Cash Flow — — 1.07M 1.04M